SCHEMBL4783557

SCHEMBL4783557

O=C(O)c1nn(-c2ccc(Cl)cc2)c2c1COc1cc(Cl)ccc1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ CCNA2 P20248 3/20 0.45
▸ CDK2 P24941 3/20 0.45
▸ CCNA1 P78396 3/20 0.45
▸ PTGS2 P35354 2/20 0.42
▸ NR1H4 Q96RI1 2/20 0.40
▸ PIK3CD O00329 2/20 0.40
▸ PIK3R2 O00459 2/20 0.40
▸ PIK3CA P42336 2/20 0.40
▸ PIK3CB P42338 2/20 0.40
▸ PIK3CG P48736 2/20 0.40
▸ PIK3R5 Q8WYR1 2/20 0.40
▸ PIK3R3 Q92569 2/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ RPA1 P27694 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ RAD52 P43351 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16709823 0.83 NR1H4 (0.55) NR1H4MAPTTP53POLB
SCHEMBL9832871 0.79 PTGS1 (0.49) CYP1A2HIF1ACCNA2CDK2CCNA1
SCHEMBL4731309 0.78 CNR2 (0.45) NR1H4LMNACNR1
SCHEMBL4729577 0.78 CNR1 (0.45) LMNACNR1
SCHEMBL2492413 0.76 CNR2 (0.52) CNR1
SCHEMBL2186114 0.76 CNR2 (0.42) CCNA2CDK2CCNA1PIK3CDPIK3R2
SCHEMBL17385520 0.76 CYP1A2 (0.35) CYP1A2HIF1ACCNA2CDK2CCNA1
SCHEMBL9832064 0.75 CCNA2 (0.35) CYP1A2HIF1ACCNA2CDK2CCNA1
SCHEMBL11866077 0.75 CYP1A2 (0.59) CYP1A2HIF1ACCNA2CDK2CCNA1
SCHEMBL9833649 0.74 PTGS1 (0.46) CYP1A2HIF1ACCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008035356-A2 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LIMITED (IN) 2008-03-27 — — WO claimed
WO-2008035356-A2 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LIMITED (IN) 2008-03-27 — — WO disclosed
Send feedback